Conditions: Healthy Volunteers
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 48
Healthy volunteers: yes

Brief summary:
The purpose of this study is to determine if two different dosing strategies for evacetrapib will have essentially the same effect on the body. The study will also explore the effect of a low fat meal on how the body absorbs evacetrapib. This study will last at least 15 weeks, not including screening. Screening is required within 28 days prior to the date of first dosing.

Detailed description:

Arms:
arm 1: Single oral dose of 1 tablet of evacetrapib on Day 1 of up to three of five periods arm 2: Single oral dose of 2 tablets of evacetrapib on Day 1 of up to three of five periods

Interventions: intervention 1: Evacetrapib
Intervention descriptions: intervention 1: Administered orally

Protocol document: